Existing Drugs That Could Treat COVID-19 Discovered

Notably, four of these compounds were found to work synergistically with remdesivir, a current standard-of-care treatment for COVID-19, said new study.

21 existing drugs that stop the replication of SARS-CoV-2, the virus that causes COVID-19 have been discovered by a global team of scientists.

Notably, four of these compounds were found to work synergistically with remdesivir, a current standard-of-care treatment for Covid-19, said the study published in the journal Nature.

Aggressive Testing Helps Delhi Grips With COVID-19?
Aggressive COVID-19 testing is one of the crucial factors, which helped Delhi tide over the health crisis, but emphasized that people should not lower their guard against the viral infection, said an AIIMS doctor.

‘Of the 21 drugs that were effective at blocking viral replication, the scientists found 13 have previously entered clinical trials for other indications and are effective at concentrations, or doses, that could potentially be safely achieved in COVID-19 patients.’

"Remdesivir has proven successful at shortening the recovery time for patients in the hospital, but the drug doesn't work for everyone who receives it. That's not good enough," said senior author of the study Sumit Chanda, Professor at Sanford Burnham Prebys Medical Discovery Institute in California, US.

"As infection rates continue to rise in America and around the world, the urgency remains to find affordable, effective, and readily available drugs that can complement the use of remdesivir, as well as drugs that could be given prophylactically or at the first sign of infection on an outpatient basis."

In the study, the research team performed extensive testing and validation studies, including evaluating the drugs on human lung biopsies that were infected with the virus.

COVID-19 in Bangladesh: Corona Cases Reach 213,254, Death Toll At 2,751
Bangladesh has registered 42 deaths in the last 24 hours, taking the total fatalities to 2,751, said the health officials.

They also evaluated the drugs for synergies with remdesivir, and established dose-response relationships between the drugs and antiviral activity.

Two are already approved by the US Food and Drug Administration: astemizole (allergies), clofazamine (leprosy) and remdesivir has received emergency use authorization from the agency (Covid-19).

Kerala Records 1,103 New COVID-19 Cases
Kerala has reported 1,103 new cases of COVID-19, said Health Minister K.K. Shailaja. She said 1,049 more patients were cured of the disease.

Four worked synergistically with remdesivir, including the chloroquine derivative hanfangchin A (tetrandrine), an antimalarial drug that has reached Phase 3 clinical trials.

"This study significantly expands the possible therapeutic options for Covid-19 patients, especially since many of the molecules already have clinical safety data in humans," said Chanda.

Yoga and Meditation: Potential Adjunctive Treatments for COVID-19
Anti-inflammatory and other beneficial effects of yoga and meditation practices make them potential adjunctive therapies of COVID-19, finds a new study.

"This report provides the scientific community with a larger arsenal of potential weapons that may help bring the ongoing global pandemic to heel."

The researchers are currently testing all 21 compounds in small animal models and "mini lungs," or lung organoids, that mimic human tissue.

If these studies are favourable, the team will approach the US FDA to discuss clinical trials evaluating the drugs as treatments for Covid-19.

"Based on our current analysis, clofazimine, hanfangchin A, apilimod and ONO 5334 represent the best near-term options for an effective Covid-19 treatment," said Chanda.

"While some of these drugs are currently in clinical trials for Covid-19, we believe it's important to pursue additional drug candidates so we have multiple therapeutic options if SARS-CoV-2 becomes drug resistant."

The drugs were first identified by high-throughput screening of more than 12,000 drugs from the ReFRAME drug repurposing collection -- the most comprehensive drug repurposing collection of compounds that have been approved by the FDA for other diseases or that have been tested extensively for human safety.

Source-IANS